DTR Stenotrophomonas maltophilia pneumonia: the unseen denominator and the limits of inference - Takeaways - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Difficult-to-Treat Stenotrophomonas maltophilia Pneumonia: Unrecognized Factors and the Challenges of Interpretation

  • By

  • Xiaoqin Li

  • Lei Zhang

  • Li Peng

  • September 21, 2026

Share

  • 1

    The study by Mokrani et al. focuses on antibiotic regimens for difficult-to-treat Stenotrophomonas maltophilia pneumonia in ICU patients.

  • 2

    Case ascertainment relied on microbiology database searches, omitting clinically diagnosed cases with negative respiratory cultures.

  • 3

    The study's findings may favor patients with greater bacterial burden, potentially skewing the representation of the infection's natural history.

  • 4

    Quantitative MIC data were limited, with susceptibility testing methods varying across centers, raising concerns about generalizability.

  • 5

    The authors suggest focusing on microbiologically confirmed cases and standardizing susceptibility testing in future research.

Original Source(s)

Related Content